What does CUSIP 641288105 represent in this 13F holders report?

CUSIP 641288105 is the security identifier for NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

How many institutions held NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share in Q1 2023?

24 institutional investors reported NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share for Q1 2023. Use the holders table for investor-level position and value details.

NeuroPace Inc - Common Stock, par value $0.001 per share (NPCE)

CUSIP: 641288105

Q1 2023 13F Holders as of 31 Mar 2023

Security type / class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 17,670,188
Total 13F value: $81,990,736
Share change: +313,164
SEC-reported price per share: $4.64
Number of holders: 24
Value change: +$1,754,483
Number of buys: 13
Number of sells: 5
Shares outstanding: 34,207,386

Security key

641288105

Report period

Q1 2023

Institutions

Top holders

NPCE full security history Ownership snapshot Full 13F holder table NeuroPace Inc SEC filings NeuroPace Inc company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of NPCE - NeuroPace Inc - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

KCK LTD.

Disclosed value leader

KCK LTD.

Comparable rows

15/15

Latest evidence

31 Dec 2022

13F Lead comparable stake: 16% Showing 1-6 of 15 holder rows.

Quick read

KCK LTD. leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens KCK LTD.'s linked filing trail.

Comparable ownership Top 5

KCK LTD. 16%

ORBIMED ADVISORS LLC 12%

Soleus Capital Management, L.P. 6.9%

MORGAN STANLEY 6.4%

FMR LLC 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
KCK LTD.	13F Company 13F	16%	$8,375,455 5,621,111 shares	—	31 Dec 2022
ORBIMED ADVISORS LLC	13F Company 13F	12%	$5,978,299 4,012,281 shares	—	31 Dec 2022
Soleus Capital Management, L.P.	13F Company 13F	6.9%	$3,529,814 2,369,003 shares	—	31 Dec 2022
MORGAN STANLEY	13F Company 13F	6.4%	$3,261,004 2,188,593 shares	—	31 Dec 2022
FMR LLC	13F Company 13F	4.2%	$2,160,390 1,449,926 shares	—	31 Dec 2022
MILLENNIUM MANAGEMENT LLC	13F Company 13F	2%	$1,031,000 691,899 shares	—	31 Dec 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

17,670,188

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q1 2023 Shares	Share Diff	Share Chg %	Q1 2023 value	Q1 2023 value	Value change	Value Chg %